“…Treatment with bone morphogenetic protein (BMP) and/or inhibitors of the activin/nodal pathway have been used for deriving trophoblasts (1, 6 -8, 10, 12-15, 17, 19, 22-29, 33, 38). However, the signaling pathways that guide terminal trophoblast differentiation toward a syncytial fate versus an extravillous fate are poorly understood (39). Trophoblasts of the human placenta are composed of villous cytotrophoblasts (vCTBs), syncytiotrophoblasts (STBs), and extravillous cytotrophoblasts (EVTs) (40).…”